jmp software version 11.2.1 (SAS institute)
SAS institute is a verified supplier 
90
Structured Review
SAS institute
jmp software version 11.2.1
Jmp Software Version 11.2.1, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jmp+version+11%2E2%2E1+software/jmp+version+11+0/pmc09816656-231-14-18
Average 90 stars, based on 1 article reviews
Jmp Software Version 11.2.1, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/jmp+version+11%2E2%2E1+software/jmp+version+11+0/pmc09816656-231-14-18
Average 90 stars, based on 1 article reviews
jmp software version 11.2.1 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Localizing small lung lesions in video-assisted thoracoscopic surgery via radiofrequency identification marking. Article Snippet: Article Title: IL-6 blockade suppresses the blood-brain barrier disorder, leading to prevention of onset of NMOSD Article Snippet: Statistical analyses were performed using IBM SPSS Statistics (International Business Machines Corporation, Armonk, NY, USA) or Article Title: Age-Related Changes in Item Responses to the Patient Health Questionnaire-9: Evidence From the National Health and Nutrition Examination Survey Article Snippet: Analyses were performed using Article Title: Three-dimensional culture models mimic colon cancer heterogeneity induced by different microenvironments Article Snippet: Statistical analyses were performed using the Article Title: Anti-IL-6 receptor antibody improves pain symptoms in mice with experimental autoimmune encephalomyelitis. Article Snippet: Statistical analyses were performed using Article Title: MITF suppression improves the sensitivity of melanoma cells to a BRAF inhibitor. Article Snippet: Microphthalmia-associated transcription factor (MITF) is expressed in melanomas and has a critical role in melanocyte development and transformation.. Because inhibition of MITF inhibits cell growth in melanoma, MITF is a potential therapeutic target molecule.. Here, we report the identification of CH6868398, which has a novel chemical structure and suppresses MITF expression at the protein level in melanoma cells. Article Title: Consolidation with 90 Yttrium-ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma. Article Snippet: Katsuhiro Miura (Orcid ID: 0000-0002-1538-3804) Masaki Iino (Orcid ID: 0000-0002-3471-0890) Consolidation with 90Yttrium-ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma Katsuhiro Miura1, Hideki Tsujimura2, Yasufumi Masaki3, Masaki Iino4, Jun Takizawa5, Yoshinobu Maeda6, Kazuhiko Yamamoto7, Shinobu Tamura8†, Akiyo Yoshida9, Hideo Yagi10, Isao Yoshida11, Koichi Kitazume12, Taro Masunari13, Ilseung Choi14, Yasutaka Kakinoki15, Ritsuro Suzuki16, Tadashi Yoshino17, Shigeo Nakamura18, Yoshihiro Hatta1, Takashi Yoshida19, and Masatoshi Kanno20 1Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.. 2Division of Medical Oncology, Chiba Cancer Center, Chiba, Japan.. 3Department of Hematology and Immunology, Kanazawa Medical University, Ishikawa, Japan. |